新闻
21 小时之前
Cidara Therapeutics to Present Late-Breaking Clinical Phase 2 Data on CD388 at ID Week 2025
快速通道临床结果
21 小时之前
免疫疗法临床结果
DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss
孤儿药临床结果快速通道临床研究基因疗法
Abivax Announces Late-Breaking Presentation of 8-Week ABTECT Trial Results with Updated Safety Data
临床结果
Connect Biopharma Presents Data Supporting Rademikibart at the European Respiratory Society Congress 2025
临床结果引进/卖出
AdvanCell to Highlight the Potential of Pb-212-based Targeted Alpha Therapies for Cancer at EANM’25
放射疗法
Novartis to showcase transformative data in advanced prostate and early breast cancer at ESMO 2025
临床结果
Cidara Therapeutics Announces Expanded and Accelerated Phase 3 Plan for CD388, a Non-Vaccine Preventative of Seasonal Influenza
快速通道疫苗临床结果
免疫疗法
Skye Presents Phase 1b Data for its Peripheral CB1-inhibiting Antibody, Nimacimab, at European Association for the Study of Diabetes (EASD) Annual Meeting
临床结果